Wilson disease (WD) is a genetic disorder of copper metabolism associated with severe hepatic, neurological, and psychiatric abnormalities. In WD, the billiary copper excretion is impaired and copper accumulates in tissues, particularly in the liver and the brain. The affected gene, ATP7B, encodes the copper transporting ATPase, Wilson disease protein (WNDP). WNDP has six copper binding sites in the N-terminal portion of the molecule. Each site includes the conserved amino acid sequence MXCXXC, and binds 1 Cu(I) through its 2 cysteine residues. We performed X-ray absorption studies at the Cu Kα-edge on the recombinant N-terminal domain of WNDP (N-WNDP). Copper was bound to N-WNDP either in vivo or in vitro in the presence of different reducing agents. We found that in N-WNDP copper is predominantly coordinated in a linear fashion by two cysteines, with the appearance of a Cu-Cu interaction when all metal binding sites are filled. Increasing amounts of reducing agents containing sulfide or phosphine groups led to binding of the exogenous ligands to copper thereby increasing the coordination number of copper from two to three. To better understand the role of copper in WD, we utilized livers of the 6-weeks-old Atp7b-/-mice (an animal model for WD) in which the copper concentration was 10-20-fold higher compared to that of the control mice. The distribution of copper in hepatocytes was evaluated by synchrotron based X-ray fluorescence microprobe (SXRF). We demonstrate that we can prepare liver slices that retain copper and can detect copper with subcellular resolution. On the same sections μ-XANES (spot size: 5 micron) was used to determine the oxidation state of copper.
INTRODUCTION
Copper is an essential element for all living organisms. Because of its inherent toxicity cells have developed a mechanism by which all copper is sequestered by smaller transporter proteins and subsequently distributed within the cell in a tightly regulated metabolism. Disturbances in this metabolism cause sever disorders, such Wilson or Menkes disease. Wilson disease is a genetic disorder in which the billiary copper excretion is impaired leading to copper accumulation in tissue, predominantly liver and brain. The affected gene encodes a 165 amino acid containing copper transporting p-type ATPase (ATP7B) [1, 2] . ATP7b (Wilson disease protein, WNDP) consists of 8 membrane spanning α-helices and two larger cytosolic domains, the ATP binding domain and the metal binding domain at its N-terminal end. The N-terminal domains contain 6 metal binding motifs (each consists of about 75 amino acids) with the conserved amino acid sequence MXCXXC. This metal binding motif has been shown to bind copper in its reduced Cu(I) form through its 2 cysteine residues [3] [4] [5] [6] . Our studies were aimed at a better understanding of the copper coordination chemistry in WNDP. We conducted Cu Kα-edge XAFS on the reconstituted, recombinant N-terminal WNDP (N-WNDP). Our results showed that in in vivo and in vitro reconstituted Cu-N-WNDP is diagonally coordinated by two cysteine residues with the appearance of a Cu-Cu interaction when all metal binding sites are loaded. Furthermore, we observed binding of exogenous ligands by adding increasing amounts of reducing agents such as DTT or glutathione to the reconstituted protein which could signal a conformational change of the N-terminal domain. All results were published in detail 7 and will not be discussed further in this paper. As part of our ongoing studies to elucidate the role of copper in WD we investigated the macroscopic and microscopic distribution of hepatic copper in 6 week old control and Atp7b -/-mice (a genetically engineered animal model for WD 8 ).
Atp7b
-/-mice show the same major disease symptoms as Wilson disease patients [8] :
Copper is accumulated at high levels in the liver resulting in various pathological changes that end with bile duct cancer development in all Atp7b -/-mice older than 9 months. These mice also show a remarkable phenotype: the maximum copper concentration in the mice livers is detected at an age of approximately 6 weeks, at which point no significant pathology is observed. Subsequently, the copper levels slowly decline, while severe pathology develops culminating in liver tissue regeneration and cholangiocarcinoma [9] . We were interested in testing whether there is a copper gradient across the three zones of the acinus of a liver lobule stretching from portal triad (consisting of the hepatic artery, the portal vein and bile ducts) to the central vein. In this case, we would expect copper to be most concentrated in zone 1 (the region of the portal triad) -the entry point for copper into the liver and least concentrated in zone 3 (around the central vein). Histochemical stains traditionally used for determining the location of copper in tissue sections are notoriously unreliable and are seldom successful in the early stages of WD. We used synchrotron-based Xray fluorescence microprobe (SXRF) available at beamline (BL) 6-2 at the Stanford Synchrotron Radiation Laboratory (SSRL) to study the microscopic copper distribution in 10 μm hepatic tissue sections of control and Atp7b -/-mice. In our first attempts, we found the copper concentration in Atp7b -/-mice to be equally high throughout the 3 zones of the acinus of a lobule.
Furthermore, we performed SXRF measurements on samples that were prepared by different methods to test sample integrity versus retaining of elements in tissues. We compared samples in which the tissue was snap frozen and sectioned using a cryostat with samples that were fixed in Znformalin and subsequently embedded in paraffin.
MATERIALS AND METHODS
Sample preparation. Livers from 6 week old control and ATP7b -/-mice were obtained as saline perfused samples from Svetlana Lutsenko's laboratory at OHSU. The livers were immediately frozen in a cryomatrix (Shandon, Thermo) (method A) for sectioning or fixed in Zn formalin (method B) for embedding in paraffin. 10 μm sections were cut using either a cryostat (A) or microtome (B). The sections were mounted onto a mylar window attached to a lucite sample holder (developed in house), allowed to warm up to room temperature and dried in a desiccator. Additional sections were prepared as above, mounted on a slide, warmed up to room temperature and stained with H&E to identify morphological features as well as to test sample integrity. The copper concentration in control and ATP7b -/-samples was measured on bulk samples digested with HNO 3 using atomic absorption spectroscopy.
SXRF measurements at SSRL. SXRF measurements were carried out on BL 6-2 (rear hutch) at SSRL in June 2006. The beam was focused to either 10 x 10 μm or 3.5 x 5 μm using Kirckpatrick-Baez mirrors. The flux was 7 x 10 9 photons for a 6 x 6 μm spot. The samples were mounted at 45º to the beam and raster scanned in x and y, with step sizes of either 10 μm or 20 μm. Dwell times were 5 or 10 secs. Data were collected using the software package SUPER. Sample mounting and area selection was carried out using IDL based templates available at SSRL.
Data analysis. Data analysis was carried out using IDL based templates created by K. Ignatyev at SSRL. Fluorescent spectra were summed and exported to a spread sheet. The data were normalized to the symmetrical scatter peak and plotted. Twodimensional elemental maps with fluorescent intensity as the third dimension were created using an IDL based template created by K. Ignatyev at SSRL.
RESULTS AND DISCUSSION
We used SXRF to determine the macroscopic copper distribution in liver sections of control and ATP7b -/-mice. We also tested different sample preparations to optimize conditions for SXRF measurements. Atomic absorption measurements confirmed that samples from ATP7b -/-mice livers (prepared by method A) contained approximately 20 times as much copper as the control samples (ATP7b -/-: 245±67 ng Cu/mg wet weight; control: 12±7 ng Cu/mg wet weight). In comparison, the copper concentration in liver samples that were perfused and fixed in paraformaldehyde (2%) was consistently lower (average ATP7b -/-: 136±28 ng Cu/mg wet weight; control: 4±2 ng Cu/mg wet weight). Figure 1 shows an overlay of the fluorescence spectra of ATP7b -/-and control tissue prepared by method A. In these spectra the fluorescent counts of all points in a raster scan (200 x 200 μm, stepsize 20 μm, beamspot 10 x 10 μm) were summed and normalized to the symmetrical scatter peak. It is clearly visible that the relative copper concentration in the ATP7b -/-section is higher, while the relative concentration for all other elements remains constant (with the exception of chlorine).
We also compared the fluorescent spectra from samples (method B) of ATP7b -/-and control tissue. (graph not shown). The dominating feature was the Zn fluorescence (originating from Zn-formalin), while the copper concentration in ATP7b -/-was still elevated compared to control tissue (as we expected from the atomic absorption measurements). . The spectra were normalized to the symmetric scatter peak.
Another striking observation was that the concentration of all lighter elements (P to Ca) was drastically reduced; the elements had apparently leaked out of the tissue during the fixation process. Figure 2 shows an example of 2-dimensional elemental maps of image with false coloring. Copper is evenly distributed throughout the section and is only more concentrated in regions where other elements are more abundant as well. In summary, our initial experiments have shown that we can utilize SXRF microprobe to image copper in hepatic tissue of 6-week old ATP7b -/-and control mice. We conclude that sample preparation is important to ensure sample integrity and to retain the elemental composition. We found that minimal sample handling, as well as snap frozen samples, are preferable over samples fixed in Zn-formalin. The analysis of several sections for hepatic tissue of 6-week old ATP7b -/-mice (covering all three zones of the acinus) showed that copper accumulates evenly within a liver lobule (data only shown for one section). Future experiments will probe whether the copper distribution changes over the course of the disease in hepatic tissue of ATP7b -/-and control mice
